PRIMARY CNS TUMORS
Clinical trials for PRIMARY CNS TUMORS explained in plain language.
Never miss a new study
Get alerted when new PRIMARY CNS TUMORS trials appear
Sign up with your email to follow new studies for PRIMARY CNS TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare cancers: targeted drug repotrectinib enters trial
Disease control Recruiting nowThis study tests a drug called repotrectinib in children and young adults (up to age 25) with advanced solid tumors, lymphoma, or brain tumors that have specific gene changes (ALK, ROS1, or NTRK1-3). The goal is to find the safest dose and see if the drug shrinks tumors. Particip…
Matched conditions: PRIMARY CNS TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Turning Point Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Genetic blueprint of tumors may guide smarter cancer treatment
Knowledge-focused Recruiting nowThis study looks at whether detailed genetic testing of tumor tissue or blood can help doctors make better treatment decisions for people with advanced solid tumors or primary brain cancers. About 550 participants will have their tumors genetically profiled, and a smaller group w…
Matched conditions: PRIMARY CNS TUMORS
Sponsor: The Belgian Society of Medical Oncology • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC